Investors

A pharmaceutical drug developer with a strong investment case

Calendar


November 11, 2020 - Interim report third quarter 2020
November 9-23, 2020 - Subscription period rights issue
November 9-12, 2020 - Trading in subscription rights
December 11, 2020 - Extra General Meeting
February 17, 2021 - Year end report

Share

Twitter
LinkedIn

Contact us

Address: Grev Turegatan 11 C, 114 46 Stockholm, Sweden

Phone: +46 8 679 72 10

E-mail: info@pledpharma.com